Intellego announces preliminary 2024 numbers and updates on 2025 progress
Prenumeration
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Bioteknik |
Intellego’s annual net revenue for 2024 is expected to reach approximately SEK 267 million, which is approximately 11 percent lower than originally expected. The lower revenue is caused by the fact that deliveries to customers, valued at approximately SEK 30 million, occurred in January 2025 instead of December 2024. The SEK 267 million is an increase of approximately 43 percent from 2023.
The EBIT for the full year of 2024 is projected to reach approximately SEK 110 million, which is in line with expectations and a growth of approximately 32 percent from 2023.
Short-term liquid assets by the end of the year were approximately SEK 50 million.
2025 has started well with revenue of SEK 70 million already in Q1, and Intellego is expecting to have over SEK 100 million in cash by the end of 2025.
The numbers are preliminary, and the final Q4 numbers will be presented in the Q4 report, which will be published on the 28th of February.